This report is the first, to our knowledge, to describe the apparent usage of the inherently autoreactive VH4-34 gene by anti-CCP2 antibodies in patients with RA from the very earliest signs of disease. This evidence concerns the gene AGBL2 and rheumatoid arthritis.